Pre-Test Fear and Confidentiality Shape HIV Screening Acceptability in Somalia

In Somalia, the decision to get tested for HIV carries weight that extends far beyond the laboratory result. A person walking into a clinic for a premarital screening or routine checkup does not simply wonder whether they carry the virus. They wonder what happens if the test comes back positive—who will find out, what their family will say, whether their partner will leave them, whether a health worker will tell someone they trusted. This anticipatory dread, before the test is even taken, shapes whether people seek diagnosis at all.

Researchers call this "pre-test fear": the anxiety that builds before testing about the possible medical, social, relational, or confidentiality consequences of undergoing screening or receiving a reactive result. It is a reasonable concern in Somalia, where the evidence is clear and troubling. In 2017, researchers surveyed 750 people already living with HIV across South Central Somalia, Puntland, and Somaliland. Nearly one in four—24.8 percent—reported that a health-care worker had disclosed their HIV status to other people without permission. The same survey documented that fear of losing confidentiality was a reason some communities avoided HIV counseling and testing services altogether. A separate qualitative study found widespread stigma and reluctance to seek voluntary diagnosis and treatment. These are not abstract concerns. They are documented patterns of breach and abandonment.

The context matters. Somalia's measured HIV prevalence is low. In 2018, sentinel surveillance at 20 antenatal clinics found HIV in only 9 of 9,055 pregnant women—a rate of 0.10 percent. But low prevalence does not mean low stakes. The World Health Organization emphasizes that HIV testing is more than a laboratory assay. It requires consent, confidentiality, counseling, correct results, and connection to prevention, care, and treatment. The "5 Cs," they call it. Somalia's challenge is not the size of the epidemic but the fragility of trust.

Health literacy compounds the problem. A 2025 nationwide analysis found that 67.18 percent of reproductive-age women held misconceptions about HIV transmission. Among 440 adolescents in internally displaced-person camps in Mogadishu, 69 percent had poor HIV knowledge and 84 percent held stigmatizing attitudes. These gaps in understanding mean that people approach testing not just with fear but with misinformation—they may not understand what a positive result means, what treatment can do, or why testing matters for prevention.

Premarital HIV screening presents a particular tension. Testing before marriage can serve prevention and early care. But it also entangles diagnosis with relationship decisions, family expectations, and judgments about moral suitability. A reactive result does not simply become a medical fact; it becomes evidence in a social negotiation. The 2017 Stigma Index documented spouse abandonment and other forms of enacted stigma after HIV diagnosis or disclosure. When testing is linked to marriage, the stakes shift from health to gatekeeping.

The researchers propose a framework: privacy-first HIV screening that translates WHO principles into practical steps. The laboratory itself must become a trust environment, not just a technical one. This means private informed consent, brief pre-test information, confidential workflows, clear pathways for confirming reactive results, and active linkage to care. For premarital testing specifically, it means separating couple education from individual consent and disclosure—preserving the preventive value of couple engagement without converting screening into a punitive social process. A reactive screening result should trigger confirmation and counseling, not immediate social or administrative consequences.

But the framework is not yet proven. Somalia has examples of confidentiality-protective practice—the 2018 sentinel survey demonstrated that coded documentation and trained counselors are operationally feasible. Yet consistent implementation and patient confidence cannot be assumed. The legal and policy environment varies across Somali jurisdictions. The 2019 legal-environment assessment found that Somaliland's HIV policy emphasized voluntary testing and strict confidentiality, while Federal and Puntland policies were still in draft form at that time.

What comes next is research. Researchers need a locally developed instrument to measure pre-test fear itself—to quantify the fear of a positive result, perceived confidentiality, anticipated stigma, relationship consequences, family disclosure, and trust in health workers. They need facility surveys and policy mapping to establish where premarital testing is actually offered, whether it is voluntary or required, how consent is obtained, and what happens after a reactive screen. They need implementation studies to test whether the privacy-first framework actually changes testing acceptance, completion of confirmatory testing, return for results, linkage to care, and patient-reported trust. The framework is a hypothesis, not a proven intervention. Somalia's health authorities and research institutions now have a structured starting point—but the evidence must come from Somalia itself.